Diagnostics Marks 'NHS 70' With New UK Push On AMR
Executive Summary
The National Health Service (NHS) came into being in the UK 70 years ago today, and to mark the occasion, NHS England and UK diagnostics stakeholders have officially launched a new prevention initiative: the UK AMR Diagnostic Collaborative. Its targeted actions and recommendations will help the NHS – and global systems – tackle the ever-larger-looming issue of antimicrobial resistance.
You may also be interested in...
Brits Lead Charge In Global Battle Against Antimicrobial Resistant Superbugs
During the annual BIO International conference in June, researchers from the UK – which has pushed antimicrobial resistance to front and center on the global stage – discussed ongoing efforts for incentivizing antibiotic discovery and development, and the challenges that remain when it comes to management and resolution of the world’s AMR crisis.
UK Diagnostic Fret Over Loss of Support In Evidence Centers Restructure
Changes are afoot for the four UK Diagnostic Evidence Co-operatives that help generate clinical and cost-effectiveness data for innovative IVDs. Companies worry it could mean diagnostic industry needs get lost among broad medtech targets. Also, a roundup of the British In Vitro Diagnostics Association's key priorities, including the EU IVD Regulation, procurement issues, antimicrobial resistance, and of course, Brexit, highlighted at the group's 2016 annual meeting.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.